Current Ratio

A current ratio of 4.49x means Bio-Techne has $4.49 in current assets for every $1 of current liabilities, indicating it can easily cover short-term obligations.

That level is well above the healthcare sector median of 2.02x, placing the company in the 76th percentile among sector peers. No trend data is available: the year-over-year change, quarter-over-quarter change, and the direction over the last eight quarters are all reported as N/A. Without a trend, it is impossible to tell whether liquidity is improving or weakening, so the investment implication hinges solely on the current high level — low default risk, but possibly idle cash that could be deployed for growth. This metric supports the overall NEUTRAL verdict: strong liquidity reduces downside risk, but the absence of a trend and the neutral rating suggest no immediate catalyst for outperformance.

Frequently Asked Questions

Closest Sector Peers